Reversible Magnesium Precipitation for Hot-Start PCR

Information

  • Research Project
  • 6551492
  • ApplicationId
    6551492
  • Core Project Number
    R43GM066632
  • Full Project Number
    1R43GM066632-01
  • Serial Number
    66632
  • FOA Number
  • Sub Project Id
  • Project Start Date
    8/1/2002 - 23 years ago
  • Project End Date
    1/31/2004 - 21 years ago
  • Program Officer Name
    SWAIN, AMY L
  • Budget Start Date
    8/1/2002 - 23 years ago
  • Budget End Date
    1/31/2004 - 21 years ago
  • Fiscal Year
    2002
  • Support Year
    1
  • Suffix
  • Award Notice Date
    8/1/2002 - 23 years ago

Reversible Magnesium Precipitation for Hot-Start PCR

DESCRIPTION (provided by applicant): We have been investigating strategies for novel methods of hot start for PCR. One such strategy involves the sequestering of a critical component of the reaction until the reaction temperature is sufficient to ensure selective annealing of PCR primers. We have investigated reversible precipitates of Mg as a method of sequestering Mg2+ ions, which are a critical component of PCR. Many PCR analyses benefit from or require a hot start, particularly those with rare targets or those with compromised DNA templates, such as diagnostic or forensic analyses. In a normal (room temperature) start, the primers can bind to non-specific sequences, or each other, during reaction setup, which can result in the amplification of competitive or inhibitory products. Current methods of achieving a hot start are tedious, expensive, and/or unreliable. We have identified a precipitated form of Mg that is solublized by thermocycling, but is stable enough at room temperature to inhibit polymerase activity. We have also determined that PCR reactions performed with this reversibly precipitated Mg have the benefit of a hot start. We are proposing to simplify and optimize this reversible precipitate technology for standard PCR and extend it to specialized PCR applications, multiplex PCR, Long and Accurate PCR, and even those applications that use other Mg2+ ion dependent enzymes, such as cDNA synthesis by reverse transcriptases.

IC Name
NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES
  • Activity
    R43
  • Administering IC
    GM
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    100000
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    821
  • Ed Inst. Type
  • Funding ICs
    NIGMS:100000\
  • Funding Mechanism
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    DNA POLYMERASE TECHNOLOGY, INC.
  • Organization Department
  • Organization DUNS
    124524989
  • Organization City
    ST. LOUIS
  • Organization State
    MO
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    631041304
  • Organization District
    UNITED STATES